Perbak Capital Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-869
Closed -$220K 380
2025
Q4
$220K Sell
869
-1,696
-66% -$426K 0.07% 204
2025
Q3
$635K Buy
2,565
+1,017
+66% +$243K 0.11% 200
2025
Q2
$372K Buy
+1,548
New +$360K 0.08% 223

Other funds holding STE

Perbak Capital Partners's STE Position: Q1 2026 in Review

Perbak Capital Partners sold out of Steris (STE) in Q1 2026, closing a stake of 869 shares — an estimated $220K sold.

Perbak Capital Partners first reported a position in STE in Q2 2025 and held it in 3 quarters. The position peaked at $635K in Q3 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Perbak Capital Partners reported no remaining Steris position as of Q1 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 869 Steris shares in Q1 2026, an estimated $220K.
  • Perbak Capital Partners first reported a position in Steris in Q2 2025 and held it in 3 quarters.
  • Perbak Capital Partners's Steris position peaked at $635K in Q3 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.